About AIkido Pharma
AIkido Pharma is a company based in New York (United States) founded in 1967. AIkido Pharma has completed 2 acquisitions, including CBM Biopharma and DatChat. AIkido Pharma offers products and services including AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aikido Labs Inc.
-
Annual Revenue
$9 K (USD)0as on Dec 31, 2019
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.46 M (USD), Post-IPO
Jul 01, 2015
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
CBM Biopharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AIkido Pharma
AIkido Pharma offers a comprehensive portfolio of products and services, including AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform.
Therapeutics targeting acute myeloid and lymphoblastic leukemia.
Treatment for pancreatic cancer based on preclinical results.
Therapeutic for prostate cancer with positive preclinical outcomes.
Broad-spectrum antiviral drugs licensed from universities.
People of AIkido Pharma
Unlock access to complete
Advisor Team
4 people
Leadership Team
3 people
Chairman Team
1 people
Partner Team
1 people
Unlock access to complete
Funding Insights of AIkido Pharma
Investments & Acquisitions by AIkido Pharma
AIkido Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CBM Biopharma and DatChat.
Investment portfolio details for AIkido Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for cancer treatment are developed.
|
Locked | Locked | 2018 | Locked | |
|
Ephemeral messaging platform offered for enterprise social networking.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for AIkido Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AIkido Pharma
Detailed financials for AIkido Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aikido Pharma Comparisons
Peer comparison for AIkido Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AIkido Pharma
Detailed competitors of AIkido Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aikido Pharma
Complete news archive for AIkido Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AIkido Pharma
AIkido Pharma was founded in 1967 and raised its 1st funding round 45 years after it was founded.
AIkido Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.
Anthony C. Hayes is the current CEO of AIkido Pharma.
Annual revenue of AIkido Pharma is $9K as on Dec 31, 2019.
AIkido Pharma was founded in 1967 in New York, United States, within the biotechnology sector. Therapeutics for cancer treatment are developed, with pipelines targeting pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The acute myeloid leukemia drug is formulated as a targeted therapy to address multiple resistance mechanisms. Operations are centered on advancing these oncology-focused drug candidates.
AIkido Pharma offers AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform.
AIkido Pharma has made 2 acquisitions, including CBM Biopharma, and DatChat.